Eubicarbonatemic Hydrogen Ion Retention and CKD Progression

Small-scale trials in patients with chronic kidney disease (CKD) 3-5 have shown that hypobicarbonatemic metabolic acidosis promotes progression of CKD. Accordingly, the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline suggests base administration to patients with CKD when serum bicar...

Full description

Bibliographic Details
Main Author: Nicolaos E. Madias
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Kidney Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059521001023